Latest Insider Transactions at Health Lynked Corp (HLYK)
This section provides a real-time view of insider transactions for Health Lynked Corp (HLYK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HealthLynked Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HealthLynked Corp's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 24
2024
|
David Rosal Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
28,333
+31.37%
|
$0
$0.08 P/Share
|
Jun 20
2024
|
David Rosal Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
33,667
+50.0%
|
$0
$0.08 P/Share
|
Sep 27
2023
|
Heather Monahan Director |
BUY
Grant, award, or other acquisition
|
Direct |
408,163
+25.67%
|
-
|
Sep 27
2023
|
Robert P Gasparini Director |
BUY
Grant, award, or other acquisition
|
Direct |
408,163
+12.41%
|
-
|
Sep 27
2023
|
Paul Hobaica Director |
BUY
Grant, award, or other acquisition
|
Direct |
408,163
+41.77%
|
-
|
Sep 27
2023
|
Daniel L. Hall Director |
BUY
Grant, award, or other acquisition
|
Direct |
408,163
+25.67%
|
-
|
Jan 27
2023
|
George O'Leary Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+5.11%
|
-
|
Jan 27
2023
|
Michael T Dent Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+1.63%
|
-
|
Dec 08
2022
|
Heather Monahan Director |
BUY
Grant, award, or other acquisition
|
Direct |
536,193
+40.94%
|
-
|
Dec 08
2022
|
Daniel L. Hall Director |
BUY
Grant, award, or other acquisition
|
Direct |
536,193
+40.94%
|
-
|
Dec 08
2022
|
Robert P Gasparini Director |
BUY
Grant, award, or other acquisition
|
Direct |
536,193
+17.82%
|
-
|
Oct 20
2022
|
George O'Leary Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+31.27%
|
-
|
Dec 21
2021
|
George O'Leary Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+0.42%
|
-
|
Dec 21
2021
|
Michael T Dent Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+0.07%
|
-
|
Nov 12
2021
|
Daniel L. Hall Director |
BUY
Grant, award, or other acquisition
|
Direct |
68,942
+22.95%
|
-
|
Nov 12
2021
|
Robert P. Mino Director |
BUY
Grant, award, or other acquisition
|
Direct |
68,942
+9.82%
|
-
|
Nov 12
2021
|
Heather Monahan Director |
BUY
Grant, award, or other acquisition
|
Direct |
68,942
+22.95%
|
-
|
Nov 12
2021
|
Robert P Gasparini Director |
BUY
Grant, award, or other acquisition
|
Direct |
68,942
+3.45%
|
-
|
Jul 21
2021
|
Robert P Gasparini Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
312,250
+14.93%
|
$0
$0.1 P/Share
|
Apr 30
2021
|
Robert P Gasparini Director |
BUY
Grant, award, or other acquisition
|
Direct |
354,234
+19.45%
|
-
|
Apr 30
2021
|
Robert P. Mino Director |
BUY
Grant, award, or other acquisition
|
Direct |
289,694
+37.51%
|
-
|
Apr 30
2021
|
Heather Monahan Director |
BUY
Grant, award, or other acquisition
|
Direct |
81,288
+50.0%
|
-
|
Mar 02
2021
|
Robert P. Mino Director |
BUY
Open market or private purchase
|
Direct |
50,000
+20.59%
|
$0
$0.5 P/Share
|
Mar 01
2021
|
George O'Leary Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
50,000
+1.31%
|
$0
$0.5 P/Share
|
Jan 13
2021
|
Michael T Dent Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+0.01%
|
-
|
Jan 13
2021
|
George O'Leary Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
100,000
+2.68%
|
-
|
Jan 13
2021
|
George O'Leary Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+0.14%
|
-
|
Nov 09
2020
|
Daniel L. Hall Director |
BUY
Grant, award, or other acquisition
|
Direct |
162,575
+50.0%
|
-
|
Oct 19
2020
|
Michael T Dent Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect |
10,573,745
+11.07%
|
$0
$0.14 P/Share
|
Oct 19
2020
|
George O'Leary Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
1,130,213
+24.25%
|
$0
$0.14 P/Share
|
Oct 19
2020
|
Robert P Gasparini Director |
BUY
Other acquisition or disposition
|
Direct |
99,437
+8.2%
|
$0
$0.14 P/Share
|